Cancer Drugs Approved Quickly Often Fail To Measure Up Later https://n.pr/2EAkKJF Regulators give many cancer drugs a fast track to market while requiring drugmakers to do more studies after approval. Researchers have found the follow-up studies frequently come up short. (Image credit: J.B. Reed /Bloomberg via Getty Images) https://n.pr/2JK2pOQ May 28, 2019 at 07:56PM

Regulators give many cancer drugs a fast track to market while requiring drugmakers to do more studies after approval. Researchers have found the follow-up studies frequently come up short.

(Image credit: J.B. Reed /Bloomberg via Getty Images)

from News : NPR https://n.pr/2EAkKJF